MI Arrowhead Publishers and Conferences
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roopra, A.
Right arrow Articles by Dingledine, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roopra, A.
Right arrow Articles by Dingledine, R.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Neurologic Diseases
Molecular Interventions 1:219-228 (2001)
© 2001 American Society of Pharmacology and Experimental Therapeutics


Review

Neurological Disease: Listening to Gene Silencers

Avtar Roopra, Yunfei Huang and Raymond Dingledine

Department of Pharmacology Emory University School of Medicine 1510 Clifton Road, Atlanta, GA 30322


Cell differentiation and specialization depend on the concerted expression and repression of specific genes. Investigations of neuronal gene regulation are unifying mechanisms of up- and downregulation of gene expression that have previously been regarded as disparate.

Neurons regulate the expression of genes essential to individual neuron function through elegant combinatorial interactions among a limited number of transcription factors. In addition, an economy of regulatory control is practiced within the nucleus that belies conceptual divisions of transcription factors into "repressors" and "activators." Studies of the neural restrictive silencer element (NRSE, also known as RE1) and its repressor protein have revealed a multitude of mechanisms by which transcriptional regulation is not only elaborated in normal neuronal development, but perverted in disease states.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Formisano, K.-M. Noh, T. Miyawaki, T. Mashiko, M. V. L. Bennett, and R. S. Zukin
Ischemic insults promote epigenetic reprogramming of {micro} opioid receptor expression in hippocampal neurons
PNAS, March 6, 2007; 104(10): 4170 - 4175.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M.-Y. Kim, B. C. Jeong, J. H. Lee, H. J. Kee, H. Kook, N. S. Kim, Y. H. Kim, J.-K. Kim, K. Y. Ahn, and K. K. Kim
A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells
PNAS, August 29, 2006; 103(35): 13074 - 13079.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Kemp, J. C. Lin, and J. F. Habener
Regulation of Pax4 Paired Homeodomain Gene by Neuron-restrictive Silencer Factor
J. Biol. Chem., September 12, 2003; 278(37): 35057 - 35062.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Liu, Z. Zhuang, P. W. Hoffman, and G. Bai
Functional Analysis of the Rat N-Methyl-D-aspartate Receptor 2A Promoter: MULTIPLE TRANSCRIPTION START POINTS, POSITIVE REGULATION BY Sp FACTORS, AND TRANSLATIONAL REGULATION
J. Biol. Chem., July 11, 2003; 278(29): 26423 - 26434.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Perez-Reyes
Molecular Physiology of Low-Voltage-Activated T-type Calcium Channels
Physiol Rev, January 1, 2003; 83(1): 117 - 161.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Huang, J. J. Doherty, and R. Dingledine
Altered Histone Acetylation at Glutamate Receptor 2 and Brain-Derived Neurotrophic Factor Genes Is an Early Event Triggered by Status Epilepticus
J. Neurosci., October 1, 2002; 22(19): 8422 - 8428.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.